Heart transplantation (HTx) is the gold standard therapy to improve quality and quantity of life in end-stage heart failure patients. However, recipients are at risk of experiencing allograft rejection and post-transplant complications, in the acute as well as chronic phase. A 43-year-old man with a history of left ventricular non-compaction underwent orthotopic HTx. On Day 7, transthoracic echocardiography showed a sudden decrease in cardiac function with hypokinesis in a left ventricular anterior wall distribution. Coronary angiography revealed a large thrombus in the left main trunk. With intra-aortic balloon pump support, emergency percutaneous coronary intervention was performed. Endomyocardial biopsy showed no rejection. A left main trunk thrombus is rare in the early phase after HTx, but it can be a life-threatening complication. Transthoracic echocardiography is well known to be important in the management of heart transplant recipients, and coronary angiography as well as myocardial biopsy should be considered when left ventricular wall motion is impaired.
Introduction
Heart transplantation (HTx) is the gold standard therapy to improve quality and quantity of life in end-stage heart failure patients. 1 However, recipients are at risk of experiencing allograft rejection and post-transplant complications, in the acute as well as chronic phase. Here, we report an uncommon case of left main trunk (LMT) thrombosis in the acute phase of HTx.
Case report
A 43-year-old man with a history of left ventricular (LV) noncompaction received an implantable LV assist device as part of a bridge-to-transplant strategy due to advanced heart failure. Four years later, he underwent orthotopic HTx using the modified bicaval technique. The heart was obtained from donation after brain death in his or her 30s. The donor heart had a normal LV ejection fraction on transthoracic echocardiography (TTE). The total ischaemic time was approximately 4 h.
On removal of the cardiac implantable electronic device lead with an excimer laser after separation from cardiopulmonary bypass, a considerable amount of bleeding occurred from the subclavian vein, which resulted in haemorrhagic shock. Internal cardiac massage and direct current defibrillation to treat ventricular fibrillation were needed, achieving haemodynamic stability. We transfused 20 units of packed red blood cells, 30 units of platelet concentrates, and 40 units of fresh-frozen plasma during and after the operation but did not transfuse any activated factor concentrates. After the operation, the patient was transferred to the intensive care unit in a stable condition. Dobutamine, noradrenaline, and dopamine were started at rates of 5.6, 0.18, and 4.2 μg/kg/min. Noradrenaline and dopamine administrations were reduced gradually and discontinued on post-operative Days 1 and 5. Dobutamine administration was reduced gradually and continued at a rate of 1.9 μg/kg/min.
An immunosuppressive regimen of cyclosporine, mycophenolate, and prednisolone was initiated without induction therapy. Low-dose aspirin was also started. Daily TTE showed normal contraction until Day 6; however, hypokinesis in an LV anterior wall distribution was noted on Day 7. Electrocardiography showed a normal sinus rhythm (98 beats/min), and ST-segment change was not observed (Figure 1) . Renal dysfunction with a creatinine level of 1.67 mg/dL (normal, <1.07 mg/dL) was noted, but emergent catheterization was performed. Right heart catheterization indicated a mean pulmonary capillary wedge pressure of 20 mmHg and a cardiac index of 1.78 L/min/m 2 . Coronary angiography showed a thrombus-like large filling defect in the LMT (Figure 2A and B; Supporting Information, Movie S1). Thus, we decided to perform percutaneous coronary intervention (PCI) with intra-aortic balloon pump support. Intravascular ultrasound revealed a low echogenic thrombus ( Figure 3A and B). Aspiration thrombectomy was attempted, but few clots were aspirated. After debulking with an excimer laser, a 3.5 × 18 mm everolimus-eluting stent was successfully deployed at the LMT-left anterior descending artery lesion (Figure 2C and D;
Supporting Information, Movie S2). Endomyocardial biopsy was negative for cellular and antibody-mediated rejection. After PCI, his haemodynamic condition stabilized, and the intra-aortic balloon pump was removed on the next day. The maximum creatine kinase-MB level was 17 U/L (normal, <12 U/L). TTE revealed normal LV systolic function. He was discharged on Day 30. Six months after PCI, follow-up coronary angiography showed no re-stenosis at the stent site.
Discussion
An LMT thrombus is a life-threatening condition that has a severe clinical presentation involving cardiogenic shock or sudden cardiac death.
2 Acute coronary syndrome (ACS) due to acute thrombus formation is rare in the early phase after HTx. Coronary artery disease after HTx is often related to allograft vasculopathy, which is an accelerated arteriosclerosis characterized by diffuse, longitudinal, and concentric proliferation of intimal smooth muscles and the extracellular matrix in the remote phase.
3 However, ACS in the early phase after
HTx is associated with the surgical procedure, especially the biatrial anastomosis technique, tissue embolization, a postsurgical coronary air embolus, thrombosis, and coronary artery disease of the donor heart.
4
The organ donor in the present case had a low risk of coronary artery disease. Additionally, the recipient had no history of coagulation abnormality, and heparin-induced thrombocytopenia antibody was negative. 
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Several causes of LMT thrombus formation are possible. First, a small thrombus might have remained after flushing and removing blood from the donor heart. Development of a thrombus within a few days after the operation might have led to a coronary embolism.
Second, haemorrhagic shock occurred during cardiac device lead removal, and it is known that significant deceleration in blood flow under hypotension increases the risk of thrombosis and embolism formation. Although haemostasis was achieved with compression and transfusion, this is an extremely unusual complication. There might have been a thrombus in the coronary artery at the time of bleeding, and ventricular fibrillation might have occurred owing to myocardial ischaemia triggered by hypovolaemia.
Third, coronary vasospasm has been described in heart transplant recipients, 5 and it is considered as a cause of thrombosis. Administration of vasopressors or inotropic catecholamine agents is one of the risk factors of coronary vasospasm. 6 Coronary angiography was performed without intracoronary infusion of nitrates in our case, and there was no coronary artery spasm. However, as the spasm provocation test was not performed, coronary spasm could not be ruled out completely. Antibody-mediated rejection was considered in the differential diagnosis, which could lead to vascular injury, coagulation, and graft dysfunction in the form of reduced cardiac function. However, histological, immunopathological, and serological findings characteristic of antibody-mediated rejection were not noted in our case.
The presentation of ACS in heart transplant recipients is atypical because of autonomic denervation of the transplanted heart. 7 In our case, as the condition was asymptomatic and the electrocardiogram was normal, diagnosis was difficult. TTE is a useful non-invasive modality to detect LV dysfunction. It is important to perform coronary angiography as well as myocardial biopsy for diagnosis when TTE shows regionally impaired LV wall motion in heart transplant recipients.
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Movie S1. Pre-percutaneous coronary intervention cine loop with a thrombus in the left main coronary artery. Movie S2. Post-percutaneous coronary intervention cine loop with an implanted drug-eluting stent.
